Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | LATS1 | O95835 | 2/20 | 0.39 |
| ▸ | LATS2 | Q9NRM7 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.37 |
| ▸ | HIPK2 | Q9H2X6 | 2/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.36 |
| ▸ | PRKCH | P24723 | 2/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20072222 | 0.74 | ALDH1A1 (0.42) | ALDH1A1MAPTKDM4EKMT2ASMN1; SMN2 | |
| SCHEMBL20072218 | 0.73 | ALDH1A1 (0.53) | ALDH1A1MAPTKDM4EKMT2ALMNA | |
| SCHEMBL20072220 | 0.73 | ALDH1A1 (0.47) | ALDH1A1MAPTKDM4EKMT2ALMNA | |
| SCHEMBL23841177 | 0.72 | ALDH1A1 (0.50) | ALDH1A1MAPTKDM4EKMT2ALMNA | |
| SCHEMBL20990532 | 0.72 | HASPIN (0.38) | ALDH1A1MAPTKDM4ELMNASMN1; SMN2 | |
| SCHEMBL8404559 | 0.71 | CYP1A2 (0.52) | ALDH1A1MAPTKDM4EKMT2ALMNA | |
| SCHEMBL801807 | 0.71 | HIPK2 (0.45) | LMNALATS1LATS2HIPK2TRPV1 | |
| SCHEMBL23841183 | 0.70 | KDM4E (0.44) | ALDH1A1MAPTKDM4EKMT2ALMNA | |
| SCHEMBL11143217 | 0.68 | LMNA (0.62) | ALDH1A1MAPTKDM4EKMT2ALMNA | |
| SCHEMBL19321774 | 0.66 | CYP1A2 (0.46) | ALDH1A1MAPTKDM4EKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190345202-A1 | ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDES | OLIPASS CORPORATION (KR) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345202-A1 | ANDROGEN RECEPTOR ANTISENSE OLIGONUCLEOTIDES | AR, NR5A1, NR5A2 | ALDH1A1 2699/4885MAPT 3013/4885KDM4E 4345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.